ArticleCancer science2026

A Three-Dimensional Culture-Drug Sensitivity Test Predicts MDM2 Inhibitor-Sensitivity in SMARCB1/INI1-Deficient Tumors.

Hiroaki Goto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.